Banque Cantonale Vaudoise »

Alpine Immune Sciences shares owned by Banque Cantonale Vaudoise

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Banque Cantonale Vaudoise from 13F filings

Historical chart of Banque Cantonale Vaudoise investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Banque Cantonale Vaudoise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Banque Cantonale Vaudoise

Quarter filed Position value Share count Share price at filing
2024-03-31 $798k 20k 39.64

More positions owned by Banque Cantonale Vaudoise

Ubs Group SHS (UBS)
Philip Morris International (PM)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alcon Ord Shs (ALC)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Logitech Intl S A SHS (LOGI)
Visa Com Cl A (V)
Coca-Cola Company (KO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Coinbase Global Com Cl A Put Option (COIN)

View all positions for Banque Cantonale Vaudoise

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences